This has led to the use of asparaginase, the enzyme that converts asparagine to aspartate and ammonia, for the treatment of childhood acute lymphoblastic leukemia (ALL) (Haskell et al, 1969; Pieters et al, 2011). The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.